All Articles

As investors seek shelter from market swings without sacrificing growth, RILAs are booming. Pacific Life's latest enhancements signal a broader industry shift.

A new study challenges the federal monopoly on deposit insurance, arguing a private, market-based model offers a more resilient future after 2023's bank failures.

A new report reveals generative AI is ignoring decade-long SEO winners like Chegg, favoring brands like Khan Academy. The lesson? Authority is the new algorithm.

With a new Ottawa hub and a key battery project, Scout Clean Energy isn't just building infrastructure; it's shaping Ontario's energy future.

Beyond mere screens, a new wave of 'invisible' tech is turning walls into worlds, driving business and reshaping how we connect. Here's what it means.

Bitget CFD's zero-fee launch and $10B daily volume signal a major push to merge crypto and TradFi. But what are the hidden costs of this convergence?

Jenne's partnership with Vida isn't just a deal; it's a signal. Advanced AI is leaving the enterprise lab and entering the mainstream via trusted resellers.

As farmers face a historic squeeze, Leaf Agriculture's new funding aims to build the data plumbing for an AI revolution, turning data chaos into profit.

A top industry award reveals it's not just Laserfiche's new agentic AI that drives a 99% renewal rate, but a deep-seated culture of customer partnership.

Emerging from stealth with $5.5M, Lium's 'agentic harness' aims to let AI understand seismic, satellite, and scientific data, unlocking new discoveries.

A landmark agreement gives Premier's 4,350-hospital network streamlined access to Bluesight’s AI-powered suite for drug diversion and supply chain management.

A groundbreaking study ranks NFL owners by their AI-rendered reputations, showing single scandals can erase decades of success, signaling a new era for PR.

Daniel Wolfe's appointment as Editor-in-Chief signals a major pivot for Digital Insurance, doubling down on AI as a definitive growth signal for the industry.

Millions suffer from chronic sciatica with few good options. A small biotech is betting on a novel, non-opioid drug to fix the problem, not just mask it.

A major financial outlook warns that geopolitical fragmentation, stubborn inflation, and a new AI arms race are creating a new reality for investors.

A seismic shift is underway in the beauty industry. The era of sprawling global supply chains is giving way to a new, agile model of local-first production.

Crum & Forster's recent marketing awards are more than trophies. They are a blueprint for how legacy firms can master innovation, from AI adoption to CEO-led narrative.

Beacon Biosignals is merging AI-driven brain monitoring with home sleep testing, creating a powerful new platform that could redefine neurological diagnostics.

Polish biotech firm Urteste S.A. enrolls its first patient in a pivotal trial for a non-invasive pancreatic cancer test, a milestone in the global race for early diagnosis.

Futuri launches TopLine Enterprise, promising massive ROI by automating sales admin. We analyze if its data-centric approach can cut through a crowded AI market.